MedTrace Logo

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

NCT03849716 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 266

Last updated 2025-07-11

No results posted yet for this study

Summary

Primary Objective:

To explore associations between biomarkers of atopic dermatitis (AD) and:

* Disease state and time course of AD,
* Disease state and evolution of selected atopic comorbid conditions,
* Effectiveness of specific AD treatments.

Conditions

  • Dermatitis Atopic

Interventions

OTHER

Blood sample

Blood samples obtained for biomarker analyses

OTHER

Cheek swab

Cheek swab obtained for genetic analysis

Sponsors & Collaborators

Principal Investigators

  • Clinical Sciences & Operations · Sanofi

Eligibility

Min Age
0 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-05
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States
  • Argentina
  • Australia
  • Brazil
  • Canada
  • Colombia
  • France
  • Mexico
  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03849716 on ClinicalTrials.gov